Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.
Katherine Davis, Biotech Deals Reporter. Katherine Davis is a biotech reporter for Axios Pro Deals. She reports on venture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results